BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 23000390)

  • 1. Pharmacology of ectonucleotidases: relevance for the treatment of cardiovascular disorders.
    Mathieu P
    Eur J Pharmacol; 2012 Dec; 696(1-3):1-4. PubMed ID: 23000390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ectonucleotidase inhibitors: a patent review (2011-2016).
    Al-Rashida M; Qazi SU; Batool N; Hameed A; Iqbal J
    Expert Opin Ther Pat; 2017 Dec; 27(12):1291-1304. PubMed ID: 28870136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Purinergic signals].
    Lazarowski ER; Schwarzbaum PJ
    Medicina (B Aires); 2009; 69(2):267-76. PubMed ID: 19435702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview of the P2 receptors.
    Boeynaems JM; Communi D; Gonzalez NS; Robaye B
    Semin Thromb Hemost; 2005 Apr; 31(2):139-49. PubMed ID: 15852217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2.
    Baraldi PG; Romagnoli R; Tabrizi MA; Bovero A; Preti D; Fruttarolo F; Moorman AR; Borea PA
    Farmaco; 2005 Mar; 60(3):185-202. PubMed ID: 15784237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of epithelial transport via luminal P2 receptors.
    Leipziger J
    Am J Physiol Renal Physiol; 2003 Mar; 284(3):F419-32. PubMed ID: 12556361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purinergic signalling at the plasma membrane: a multipurpose and multidirectional mode to deal with amyotrophic lateral sclerosis and multiple sclerosis.
    Amadio S; Apolloni S; D'Ambrosi N; Volonté C
    J Neurochem; 2011 Mar; 116(5):796-805. PubMed ID: 21214557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteoblast responses to nucleotides increase during differentiation.
    Orriss IR; Knight GE; Ranasinghe S; Burnstock G; Arnett TR
    Bone; 2006 Aug; 39(2):300-9. PubMed ID: 16616882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P2X and P2Y receptors as possible targets of therapeutic manipulations in CNS illnesses.
    Köles L; Furst S; Illes P
    Drug News Perspect; 2005 Mar; 18(2):85-101. PubMed ID: 15883618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms regulating airway nucleotides.
    Picher M
    Subcell Biochem; 2011; 55():17-49. PubMed ID: 21560043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular ATP-induced calcium signaling in mIMCD-3 cells requires both P2X and P2Y purinoceptors.
    Xia SL; Wang L; Cash MN; Teng X; Schwalbe RA; Wingo CS
    Am J Physiol Renal Physiol; 2004 Aug; 287(2):F204-14. PubMed ID: 15068972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma ectonucleotidases prevent desensitization of purinergic receptors in stored platelets: importance for platelet activity during thrombus formation.
    Cauwenberghs S; Feijge MA; Hageman G; Hoylaerts M; Akkerman JW; Curvers J; Heemskerk JW
    Transfusion; 2006 Jun; 46(6):1018-28. PubMed ID: 16734820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of P2 receptors in the growth and survival of neurons in the CNS.
    Franke H; Illes P
    Pharmacol Ther; 2006 Mar; 109(3):297-324. PubMed ID: 16102837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ectonucleotidases in the nervous system.
    Zimmermann H
    Novartis Found Symp; 2006; 276():113-28; discussion 128-30, 233-7, 275-81. PubMed ID: 16805426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purinergic receptors in gastrointestinal inflammation.
    Kolachala VL; Bajaj R; Chalasani M; Sitaraman SV
    Am J Physiol Gastrointest Liver Physiol; 2008 Feb; 294(2):G401-10. PubMed ID: 18063703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of purinergic receptors in CNS function and neuroprotection.
    Tozaki-Saitoh H; Tsuda M; Inoue K
    Adv Pharmacol; 2011; 61():495-528. PubMed ID: 21586368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ATP regulates oligodendrocyte progenitor migration, proliferation, and differentiation: involvement of metabotropic P2 receptors.
    Agresti C; Meomartini ME; Amadio S; Ambrosini E; Volonté C; Aloisi F; Visentin S
    Brain Res Brain Res Rev; 2005 Apr; 48(2):157-65. PubMed ID: 15850654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The importance of alkynyl chain presence for the activity of adenine nucleosides/nucleotides on purinergic receptors.
    Dal Ben D; Buccioni M; Lambertucci C; Marucci G; Volpini R; Cristalli G
    Curr Med Chem; 2011; 18(10):1444-63. PubMed ID: 21428896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purinergic signaling in liver disease.
    Vaughn BP; Robson SC; Longhi MS
    Dig Dis; 2014; 32(5):516-24. PubMed ID: 25034284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of ectonucleotidases in autonomic nervous functions.
    Cardoso AM; Schetinger MR; Correia-de-Sá P; Sévigny J
    Auton Neurosci; 2015 Sep; 191():25-38. PubMed ID: 26008223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.